Hepatic Artery Infusion Chemotherapy as a First‐Line Treatment in Unresectable Cholangiocarcinoma: A Systematic Review and Meta‐Analysis
HAIC demonstrates an improvement over reported survival for systemic chemotherapy alone when used as either an adjunct or in place of systemic therapy for first-line treatment in patients with cholangiocarcinoma.
Authors
- Marshall Baker
- Nathorn Chaiyakunapruk
- Courtney Scaife
- Abigail J. Alexander
- Rashid M. Muhammed
- Noah Brown
Institutions
- University of Utah (US)
- Huntsman Cancer Institute (US)
- VA Salt Lake City Healthcare System (US)
- Utah Department of Health (US)
- University of Utah Health Care (US)
Publication Details
- Journal
- Journal of Surgical Oncology
- Published
- 2026-01-26
- DOI
- https://doi.org/10.1002/jso.70196
- Primary Topic
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00